Among the transcripts measured in urine as part of the combined panels currently approved for additional PCa diagnostics are the PCA3 and TMPRSS2-ERG tests; however, neither can significantly outperform the PSA test. This evidence concerns the gene KLK3 and posterior cortical atrophy.